Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment
Source: SeekingAlpha
2025-09-04 09:03:11 ET
More on Novavax
- Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript
- Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth
- Novavax: New Vaccine, Same Old Story - Still A Sell
- Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success
- Florida to eliminate all state vaccine mandates, surgeon general says
Read the full article on Seeking Alpha
For further details see:
Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment
Novavax Inc.
NASDAQ: NVAX
NVAX Trading
-1.83% G/L:
$9.395 Last:
1,264,137 Volume:
$9.39 Open:
NVAX Latest News
February 26, 2026 08:42:07 pm
Power Hour Surge: Quantum Breakouts, Biotech Visibility, and Crypto Strategy Running into the Close
February 26, 2026 08:00:00 am
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
NVAX Stock Data
$1,428,366,166
160,874,005
0.11%
93
N/A
Biotechnology & Life Sciences
Healthcare
US
Gaithersburg
